Steven Chmura, MD

Dr. Steven Chmura specializes in treating brain, breast, and gastrointestinal cancers. An expert in radiotherapy and stereotactic radiosurgery (SRS), Dr. Chmura uses minimally invasive techniques to minimize tissue damage when diagnosing and treating cancers.

Dr. Chmura is also an expert in using intensity modulated radiation therapy (IMRT) to treat gastrointestinal malignancies such as colon, anal, and pancreatic cancers. Because the radiation is precisely shaped to avoid healthy tissue surrounding the treatment area, this technology allows physicians to target tumors with more powerful doses of radiation.

An active researcher, Dr. Chmura is the principle investigator at the University of Chicago for the Radiation Trials Oncology Group (RTOG). In this role, he is involved in national randomized studies and industry-sponsored studies. His basic science research explores improvements to current radiation approaches. For example, in collaboration with other University of Chicago researchers, Dr. Chmura is working on the development of a BH3 antagonist to increase the therapeutic ratio of radiotherapy. This research earned him the 2005 American Society for Therapeutic Radiology and Oncology (ASTRO) Young Investigator Award. Dr. Chmura is also investigating how to optimize the software used to deliver IMRT to maximize tumor cell killing.

Additionally, he was awarded the 2006 and 2008 American Association of Radiation Oncology Residents teaching Award. Dr. Chmura's teaching responsibilities include lecturing and clinical teaching of medical students and residents.